Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26286757 | 0.97 | PLA2G2A (0.37) | PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E | |
| SCHEMBL26286525 | 0.94 | PLA2G2A (0.36) | PLA2G2APLA2G4APLA2G10TSPO | |
| SCHEMBL26286379 | 0.94 | TSPO (0.37) | PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E | |
| SCHEMBL26286860 | 0.92 | PLA2G2A (0.35) | PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E | |
| SCHEMBL26286319 | 0.92 | PLA2G2A (0.35) | PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E | |
| SCHEMBL26286833 | 0.90 | PLA2G2A (0.39) | PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E | |
| SCHEMBL26287024 | 0.89 | KDM4E (0.33) | PLA2G2APLA2G4APLA2G10KDM4E | |
| SCHEMBL26286439 | 0.87 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10TSPO | |
| SCHEMBL21453754 | 0.86 | AHR (0.41) | PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E | |
| SCHEMBL21453755 | 0.85 | MAPT (0.41) | PLA2G2APLA2G4APLA2G10ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295104-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-09-21 | — | — | US | disclosed |
| US-20230295104-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295104-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | OR10J3, L1CAM, EPCAM | PLA2G2A 3935/4885PLA2G4A 4499/4885PLA2G10 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.